benefici effect calcium antagonist isradipin apolipoprotein hypertens patient object studi effect calcium antagonist isradipin plasma lipid lipoprotein apolipoprotein patient essenti hypertens four-week placebo wash-out period patient men women double-blind crossov studi sustained-releas isradipin isradipin SR standard isradipin formul nineteen patient mg/day patient mg/day lipid end placebo period week treatment isradipin treatment group lipid lipoprotein a-i level ratio apolipoprotein a-i concentr irrespect gender data level plasma a-i strong predictor coronari heart diseas isradipin formul mechan effect remain 